239 related articles for article (PubMed ID: 27470251)
1. The association of mineral metabolism with vascular access patency.
Rosenberg JE; Astor BC; Deluca HF; Yevzlin AS
J Vasc Access; 2016 Sep; 17(5):392-396. PubMed ID: 27470251
[TBL] [Abstract][Full Text] [Related]
2. VORTEC technique in central venous recanalization for haemodialysis access salvage.
Törnqvist P; Hedin U; Asciutto G; Engström J; Bountouris I; Kristmundsson T; Sterner G; Dias NV
J Vasc Access; 2016 Jan; 17(1):e3-4. PubMed ID: 26932600
[No Abstract] [Full Text] [Related]
3. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.
Matias PJ; Jorge C; Ferreira C; Borges M; Aires I; Amaral T; Gil C; Cortez J; Ferreira A
Clin J Am Soc Nephrol; 2010 May; 5(5):905-11. PubMed ID: 20203163
[TBL] [Abstract][Full Text] [Related]
4. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
5. Bilateral central vein stenosis: options for dialysis access and renal replacement therapy when all upper extremity access possibilities have been lost.
Aitken E; Jackson AJ; Kasthuri R; Kingsmore DB
J Vasc Access; 2014; 15(6):466-73. PubMed ID: 25041913
[TBL] [Abstract][Full Text] [Related]
6. Association between post-dialysis hemoglobin level and the survival of vascular access.
Nishiwaki H; Hasegawa T; Ikenoue T; Tominaga N; Yazawa M; Kawarazaki H; Shibagaki Y; Yamamoto Y; Fukuma S; Yamazaki S; Fukuhara S
J Vasc Access; 2018 Jan; 19(1):69-75. PubMed ID: 29076517
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized study of heparin-bonded graft (Propaten) versus standard graft in prosthetic arteriovenous access.
Shemesh D; Goldin I; Hijazi J; Zaghal I; Berelowitz D; Verstandig A; Olsha O
J Vasc Surg; 2015 Jul; 62(1):115-22. PubMed ID: 25770987
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D compounds for people with chronic kidney disease requiring dialysis.
Palmer SC; McGregor DO; Craig JC; Elder G; Macaskill P; Strippoli GF
Cochrane Database Syst Rev; 2009 Oct; (4):CD005633. PubMed ID: 19821349
[TBL] [Abstract][Full Text] [Related]
9. The end stage of dialysis access: femoral graft or HeRO vascular access device.
Kudlaty EA; Pan J; Allemang MT; Kendrick DE; Kashyap VS; Wong VL
Ann Vasc Surg; 2015 Jan; 29(1):90-7. PubMed ID: 24952298
[TBL] [Abstract][Full Text] [Related]
10. A two-year experience with a rapid access, self-sealing, polycarbonate urethane nanofiber vascular access graft for hemodialysis.
Ferraresso M; Bortolani EM; Amnon G
J Vasc Access; 2016 May; 17(3):210-4. PubMed ID: 27032455
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
Blair D; Byham-Gray L; Lewis E; McCaffrey S
J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
[TBL] [Abstract][Full Text] [Related]
12. The effect of implementation of an optimized care protocol on the outcome of arteriovenous hemodialysis access surgery.
Flu H; Breslau PJ; Krol-van Straaten JM; Hamming JF; Lardenoye JW
J Vasc Surg; 2008 Sep; 48(3):659-68. PubMed ID: 18572358
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of arteriovenous fistulae compared with heparin-bonded and conventional grafts for hemodialysis access.
Charlton-Ouw KM; Nosrati N; Miller CC; Coogan SM; Safi HJ; Azizzadeh A
J Vasc Access; 2012; 13(2):163-7. PubMed ID: 21983827
[TBL] [Abstract][Full Text] [Related]
14. Description and early outcomes of the hybrid graft for dialysis.
Gomez LF; Peden EK
J Vasc Access; 2017 Mar; 18(Suppl. 1):64-67. PubMed ID: 28297062
[TBL] [Abstract][Full Text] [Related]
15. Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism.
Sprague SM; Wetmore JB; Gurevich K; Da Roza G; Buerkert J; Reiner M; Goodman W; Cooper K
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1021-30. PubMed ID: 25873267
[TBL] [Abstract][Full Text] [Related]
16. Graft modification strategies to improve patency of prosthetic arteriovenous grafts for hemodialysis.
Moufarrej A; Tordoir J; Mees B
J Vasc Access; 2016 Mar; 17 Suppl 1():S85-90. PubMed ID: 26951913
[TBL] [Abstract][Full Text] [Related]
17. Initial experience with the Gore® Acuseal graft for prosthetic vascular access.
Tozzi M; Franchin M; Ietto G; Soldini G; Carcano G; Castelli P; Piffaretti G
J Vasc Access; 2014; 15(5):385-90. PubMed ID: 24980560
[TBL] [Abstract][Full Text] [Related]
18. The use of the early cannulation prosthetic graft (Acuseal™) for angioaccess for haemodialysis.
Maytham GG; Sran HK; Chemla ES
J Vasc Access; 2015; 16(6):467-71. PubMed ID: 26044892
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing dialysis arteriovenous graft survival.
Valerianova A; Kudlicka J; Chytilova E; Grauova B; Krupickova Z; Malik J
J Vasc Access; 2017 Mar; 18(2):139-143. PubMed ID: 28127730
[TBL] [Abstract][Full Text] [Related]
20. Introduction: Hemodialysis vascular access: contemporary care and future directions.
Bandyk D
Semin Vasc Surg; 2016 Dec; 29(4):143-145. PubMed ID: 28779780
[No Abstract] [Full Text] [Related]
[Next] [New Search]
